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Abstract
The analysis of the aerial parts of Bonannia graeca led to the isolation and characterization of two
new polar geranylated flavonoids (6 and 7). The structure elucidation was performed by extensive
spectroscopic methods (1D and 2D NMR) and comparison with literature data. All natural
flavonoids isolated from B. graeca (1–7) and some synthetic derivatives (8–11) were tested for
cytotoxic activity against four human tumor cell lines. Preliminary structure-activity relationship
correlations are discussed.
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1. Introduction
Bonannia graeca (L.) Halácsy, belonging to the Apiaceae family, is a rare plant growing in
several Mediterranean areas, such as the southern parts of Italy and Greece. It is known for
its toxicity against herbivores and for causing the death of lambs feeding on the aerial parts
during its blossoming season (June–July). Our previous phytochemical investigations of this
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species allowed us to isolate a new irregular diterpene, bonandiol (Bruno et al., 1984), and
five new C-geranylated flavonoids bonannione A (1), bonanniol A (2), bonanniol B (3),
bonanniol C (4) and bonannione B (5) (Figure 1) (Bruno et al., 1985; Rosselli et al., 2007a).
Compound 1 occurs in plants of Macaranga genus (Euphorbiaceae), including M.
pleiostemona (Schuetz et al., 1995) and M. alnifolia (Yoder et al., 2007), and in Schizolaena
hystrix (Sarcolaenaceae) (Murphy et al., 2005). Other papers also report its isolation from
Paulownia tomentosa (Scrophulariaceae) and P. fortunei (Smejkal et al., 2008; Duan et al.,
2007) and from Mimulus (Phrymaceae) species, such as M. aurantiacus (Hare, 2008) and M.
clevelandii (Phillips et al., 1996). In these reports, 1 is named mimulone. Compound 2 has
been isolated from Monotes africanus (Dipterocarpaceae) (Meragelman et al., 2001) and,
along with 1, from Macaranga alnifolia (Yoder et al., 2007) and Schizolaena hystrix
(Murphy et al., 2005). Several papers by various researchers have reported on the biological
properties of these compounds, including the antibacterial activity of 1 (Schuetz et al.,
1995), anti-HIV activity of 2 (Meragelman et al., 2001) and cytotoxic properties of 1
(Murphy et al., 2005; Smejkal et al., 2008).
Herein we report the isolation and characterization of two new polar flavonoids (6 and 7),
occurring as minor compounds, from B. graeca. Structure elucidation was performed by
extensive spectroscopic methods (1D and 2D NMR) and comparison with literature data.
Furthermore, as part of our ongoing research on compounds with cytotoxic activity (Bruno
et al., 2002; Bruno et al., 2005a; Rosselli et al., 2008; Bruno et al., 2005b; Rosselli et al.,
2007b; Rosselli et al., 2009), we evaluated the natural flavonoids isolated from B. graeca
(1–7) and some synthetic derivatives (8–11) (Bruno et al., 1985; Rosselli et al., 2007a)
against four human tumor cell lines.
2. Result and Discussion
The elemental analysis and ESI-MS data of compound 6 were in agreement with a formula
of C25H28O7, and its IR spectrum showed the presence of hydroxy groups (3265 cm−1), a
chelated carbonyl group (1659 cm−1), and aromatic rings (1596 cm−1). The 1H and 13C
NMR (Table 1) spectra showed a similar flavonoid ring B/C pattern to that of 5, co-
occurring in the same plant. Signals were present for a para-substituted aromatic ring (δH =
7.40, 2H, brd, H-2′ and H-6′; δC = 129.0, d, C-2′ and C-6′; δH = 6.87, 2H, brd, H-3′ and
H-5′; δC = 115.7, d, C-3′ and C-5′) bearing an oxygenated moiety (δC = 156.7, s, C-4′), an
aromatic methine group (δH = 6.00, 1H, s, H-8; δC = 91.1, d, C-8), other aromatic carbon
atoms characteristic of a 5,7-dioxygenated flavonoid, an oxygenated methine group (δC =
83.3, d, C-2) at δH = 4.99 (1H, d, H-2β) coupling with the proton at δH = 4.54 (1H, d, H-3α)
on the oxygenated methine group at δC = 72.2 (d, C-3), and for a carbonyl group. The 1H
and 13C NMR signals of the side chain indicated the presence of a trisubstituted double bond
(δH = 5.13, 1H, brt, H-7″; δC = 123.8, d, C-7″; δC = 132.4, s, C-8″) bearing two methyl
groups (δH = 1.70, 3H, s, Me-9″; δC = 25.7, q, C-9″; δH = 1.64, 3H, s, Me-10″; δC = 17.7, q,
C-10″), a third methyl group (δH = 1.30, 3H, s, Me-4″; δC = 22.7, q, C-4″) linked to an
oxygenated quaternary carbon atom (δC = 73.9, s, C-3″), and a methylene group (δH = 3.09,
2H, d, H-1″; δC = 25.9, t, C-1″) whose protons coupled with the proton (δH = 4.79, 1H, dd,
H-2″) of an oxygenated methine group at δC = 91.6 (d, C-2″). The deshielding of the latter
carbon signal indicated the presence of a dihydrofuran ring, which was confirmed by a
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correlation in the HMBC spectrum between C-7 and H-2″. HSQC and HMBC experiments
allowed us to unequivocally assign all carbon atoms and to confirm that the geranyl chain is
linked at C-6 and not at C-8, as clearly indicated by the correlation between C-5 and H-1″.
Consequently, the side chain was the same as that of 5, another geranylated flavonoid co-
occurring in the same species. We had previously determined the relative configuration of
the two stereogenic centers at C-2″ and C-3″ of 5 by using a combined approach of
extensive spectroscopic and quantum mechanical methods (Rosselli et al., 2007a). Because
the 1H and 13C chemical shifts of the side chain in 6 were almost identical with respect to
those of 5, we can presume that the two compounds have the same relative configurations at
C-2″ and C-3″. The absolute configuration of the dihydroflavonol moiety was ascertained as
shown based on an identical CD curve compared with that of 2 (Bruno et al., 1985) and
literature data (Gaffield, 1970). Consequently, this compound was assigned C-2(R), C-3(R),
C-2″ (R), C-3″ (S) stereochemistry, or the diastereoisomeric C-2(R), C-3(R), C-2″ (S), C-3″
(R) configuration, and given the trivial name bonanniol D (6).
The elemental analysis and ESI-MS data of the more polar compound 7 were in agreement
with a formula of C25H30O7. Because the compound was not soluble in CHCl3, its 1H
and 13C NMR spectra were run in MeOD (Table 2). An identical flavonoid ring B/C pattern
was found to that of 6, with signals for a para-substituted aromatic ring (δH = 7.35, 2H, brd,
H-2′ and H-6′; δC = 130.3, d, C-2′ and C-6′; δH = 6.83, 2H, brd, H-3′ and H-5′; δC = 116.2,
d, C-3′ and C-5′) bearing an oxygenated functionality (δC = 159.2 s, C-4′), an aromatic
methine group (δH = 5.85, 1H, s, H-8; δC = 96.9, d, C-8), other aromatic carbon atoms
characteristic of a 5,7-dioxygenated flavonoid, an oxygenated methine group (δC = 84.9, d,
C-2) at δH = 4.95 (d, H-2β) coupling with the proton at δH = 4.49 (d, H-3α) on the
oxygenated methine group at δC = 73.7 (t, C-3), and a carbonyl group (δC = 197.3, s, C-4).
Also, similarly to 6, the 1H and 13C NMR signals of the side chain indicated the presence of
a trisubstituted double bond (δH = 5.14, 1H, brt, H-7″; δC = 126.1, d, C-7″; δC = 131.9, s,
C-8″) bearing two methyl groups (δH = 1.69, 3H, s, Me-9″; δC = 25.9, q, C-9″; δH = 1.65,
3H, s, Me-10″; δC = 17.8, q, C-10″) and a third methyl group (δH = 1.24, 3H, s, Me-4″; δC =
27.2, q, C-4″) linked to an oxygenated quaternary carbon atom (δC = 73.7, s, C-3″).
However, in 7, the protons of the benzylic methylene group (δH = 2.58, 2H, dd, H-1″; δC =
17.8, t, C-1″) were coupled with the protons (δH = 1.62, 2H, o.s., H-2″) of a methylene
group at C-2″ (δC = 40.9, t). HSQC and HMBC experiments allowed us to unequivocally
assign all carbon atoms and to confirm that the geranyl chain is linked at C-6 and not at C-8,
as clearly indicated by the correlation between C-5 and H-1″ as well as the absence of a
dihydrofuran ring and the presence of a free hydroxy group at C-3″. The absolute
configuration of the dihydroflavonol moiety was ascertained similarly as reported above for
6. Consequently, because it was not possible to assign the absolute configuration of carbon
C-3″ either by spectroscopic (NOESY, Mosher) or chemical (Horeau) methods, compound 7
was assigned the C-2(R), C-3(R), C-3″ (S) or the diastereoisomeric C-2(R), C-3(R), C-3″ (R)
configuration, and also was given the trivial name bonanniol E.
All of the natural compounds (1–7) isolated from B. graeca and four synthetic derivatives
(8–11), prepared as previously reported (Bruno et al., 1985; Rosselli et al., 2007a), were
screened against four human tumor cell lines including KB (nasopharyngeal), KB-VIN
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(multidrug-resistant KB subline), A549 (lung), and DU145 (prostate), in order to explore
their cytotoxic selectivity and critical drug-resistance profiles. The results of the in vitro
anticancer assays (Table 3) can be correlated with certain structural features of the
compounds. In particular, the hydroxy group on C-3 generally decreased the cytotoxic
activity (1 vs 2), but only about twofold. Decreased potency also occurred when the geranyl
side chain was cyclized to a dihydrofuran ring. In fact, compounds 5, 6, 9, and 10 generally
showed lower activity and were inactive against some cell lines. On the other hand,
compounds with a cyclized dihydropyran ring (4 and 11) exhibited the highest, but modest,
cytotoxic activity. Finally, the geranyl side chain seemed to play an important role, because
the hydration of 2″–3″ double bond of this moiety produced a decrease in activity (2 vs 7).
3. Concluding remarks
To our knowledge, compounds 1 and 2 have been isolated only from one species belonging
to the family of Apiaceae, i.e. B. graeca. This plant contains many C-geranylated flavonoids
and compounds with six- or five-membered rings arising from a cyclization of the geranyl
chain. These structurally intriguing compounds have shown cytotoxic activity allowing us to
deduce some structure-activity relationships.
4. Experimental
4.1. General experimental procedures
Optical rotations were determined on a JASCO P-1010 digital polarimeter. IR spectra were
obtained on a Shimadzu FTIR-8300 spectrophotometer. 1H and 13C NMR spectra were
recorded on a Bruker Avance series 300 MHz spectrometer, using the residual solvent signal
(δ = 7.27 in 1H and δ = 77.00 in 13C for CDCl3 and δ = 3.31 in 1H and δ = 49.00 in 13C for
MeOD) as reference. 13C NMR assignments were determined by DEPT spectra. ESIMS was
obtained with an Applied Biosystem API-2000 mass spectrometer. Elemental analysis was
carried out with a Perkin-Elmer 240 apparatus. CD data were obtained by a Jasco J-715
spectropolarimeter. Merck Si gel (70–230 mesh), deactivated with 15% H2O, was used for
column chromatography. Preparative TLC was performed using Merck glass plates (product
code 1.13895.0001).
4.2. Plant material
The aerial parts of Bonannia graeca (L.) Halácsy were collected at Quacella, Piano
Battaglia, 80 km SE of Palermo, Sicily, Italy, in July 2006. A typical specimen was
identified by Prof. F. M. Raimondo, University of Palermo, and has been deposited in the
Herbarium of the Botanical Science Department, Palermo, Italy (voucher number PAL
06/326).
4.3. Extraction and isolation
The dried and finely powdered aerial parts of B. graeca (800 g) were extracted with Me2CO
(3 × 5 L) at room temperature for one week. After filtration, the solvent was evaporated to
yield a gum (50 g), which was subjected to chromatography on a dry-packed silica gel
column eluting with a solvent gradient from 100% petroleum ether to 100% EtOAc. The
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fraction eluted with petroleum ether/EtOAc (4:1) yielded bonandiol (4 g). The fraction
eluted with petroleum ether/EtOAc (3:2), was further purified by column chromatography
with petroleum ether/EtOAc (7:3) as eluent to afford, in order of increasing polarity,
bonannione A (1, 1.8 g), bonanniol C (4, 60 mg), bonannione B (5, 40 mg), bonanniol A (2,
3.2 g) and bonanniol B (3, 0.9 g). The most polar sub-fraction was further purified by
preparative TLC with diethyl ether/petroleum ether (1:1) yielding 20 mg of bonanniol D (6).
The fraction eluted with petroleum ether/EtOAc (1:1) was subjected to preparative TLC
with diethyl ether/petroleum ether (4:1) as eluent to afford 2 mg of bonanniol E (7).
4.3.1. Bonanniol D (6)—Amorphous solid; [α]D25 −5.8° (c 1.03, CHCl3); IR (film) νmax
3265, 2924, 1659, 1596, 1462, 1377, 1113, 1094, cm−1; 1H NMR (CDCl3, 300 MHz) see
Table 1; 13C NMR (CDCl3, 75.4 MHz) see Table 1; ESIMS (positive mode) m/z 479 [M
+K]+ (26), 463 [M+Na]+ (100); ESIMS (negative mode) m/z 439 [M-H]− (100); CD
(MeOH) [θ]332nm +710, [θ]294nm −33093; anal. C 60.20%, H 6.37%, calcd for C25H28O7, C
68.17%, H 6.41%.
4.3.2. Bonanniol E (7)—Amorphous solid; [α]D25 −30.0° (c 0.21, MeOH); IR (film) νmax
3280, 2935, 1661, 1600, 1472, 1365, 1080, cm−1; 1H NMR (MeOD, 300 MHz) see Table
2; 13C NMR (MeOD, 75.4 MHz) see Table 1; 13C NMR (CDCl3/MeOD, 9:1, 75.4 MHz) see
Table 2; ESIMS (positive mode) m/z 465 [M+Na]+ (100); ESIMS (negative mode) m/z 441
[M−H]− (100); CD (MeOH), [θ]294nm −43098; anal. C 67.83%, H 6.85%, calcd for
C25H30O7, C 67.86%, H 6.83%.
4.4. Synthesis of Compounds 8–11
Compounds 8–11 were synthesized as previously reported (Bruno et al., 1985; Rosselli et
al., 2007a).
4.5. In vitro cytotoxicity assay
An in vitro anticancer assay established by NCI was used as described briefly below
(Rubinstein et al., 1990). All stock cultures were grown in T-25 flasks. Freshly trypsinized
cell suspensions were seeded in 96-well microliter plates with compounds added from
DMSO-diluted stock. The plates were incubated for an additional 72 h after attachment and
test compound addition, and the assay was terminated by addition of 10% trichloroacetic
acid. Then, 0.4% sulforhodamine B (SRB) dye in 1% HOAc was added to stain the cells for
10 min. Unbound dye was removed by repeated washing with 1% HOAc and the plates were
air dried. Bound stain was subsequently dissolved with 10 mM trizma base, and the
absorbance read at 515 nm. Fifty percent growth inhibition (GI50) was calculated as the
concentration of agent that caused a 50% reduction in the net protein increase in control
cells during the incubation. The mean GI50 is the concentration of agent that reduces cell
growth by 50% under the experimental conditions and is the average from at least three
independent determinations. Variation between replicates was no more than 5% of the mean.
The following human tumor cell lines were used in the assay: KB (nasopharynx), KB-VIN
(vincristine-resistant KB subline), A549 (lung), DU145 (prostate).
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Structures of compounds 1–11.
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Table 1
NMR spectroscopic data of compound 6a
Position. δH mult. (J in Hz) δCc HMBC (H)
2β 4.99 d (12.0) 83.3 d 2′, 6′, 3
3α 4.54 d (12.0) 72.2 d 2
4 - 195.7 s 2, 3
5 - 157.8 s OH, 1″
6 - 106.5 s OH, 8, 1″
7 - 169.4 s 8, 2″, 1″
8 6.00 s 91.1 d
9 - 163.7 s 8
10 - 100.9 s OH, 8
1′ - 127.8 s 3′, 5′, 2, 3
2′ 7.40 brd (8.4) 129.0 d 2
3′ 6.87 brd (8.4) 115.7 d
4′ - 156.7 s 2′, 6′, 3′, 5′
5′ 6.87 brd (8.4) 115.7 d
6′ 7.40 brd (8.4) 129.0 d 2
1″ 3.09 d (2H) (8.7) 25.9 t
2″ 4.79 dd (8.7, 8.7) 91.6 d 1″, 5″, 4″
3″ - 73.9 s 1″, 5″, 4″
Me-4″ 1.30 (3H) s 22.7 q 2″, 5″
5″ 1.53b (2H) 36.6 t 2″, 6″, 4″
6″ 2.13 (2H) m 21.9 t
7″ 5.13 brt (6.3) 123.8 d 6″, 9″, 10″, 5″
8″ - 132.4 s 6″, 9″, 10″
Me-9″ 1.70 (3H) s 25.7 q 7″, 10″







Multiplicity has been determined by DEPT experiments and assignments have been made by HSQC.
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Table 2
NMR spectroscopic data for compound 7a
Position. δH mult. (J in Hz) δCc δCc,d HMBC (H)
2β 4.95 d (12.0) 84.9 d 83.2 d 2′, 6′, 3
3α 4.49 d (12.0) 73.7 d 72.3 d 2
4 - 197.3 s 195.9 s 2, 3
5 - 162.4 s 160.7 s
6 - 111.3 s 109.7 s 8, 1″, 2″
7 - 162.3 s 164.9 s 8, 1″
8 5.85 s 96.9 d 95.6 d
9 - 162.3 s 160.7 s 8
10 - 101.0 s 100.1 s 8
1′ - 129.7 s 127.4 s 3′, 5′, 2, 3
2′ 7.35 brd (8.4) 130.3 d 128.9 d 2
3′ 6.83 brd (8.4) 116.2 d 115.5 d
4′ - 159.2 s 157.5 s 2′, 6′, 3′, 5′
5′ 6.83 brd (8.4) 116.2 d 115.5 d
6′ 7.35 brd (8.4) 130.3 d 128.9 d 2
1″ 2.58 (2H) dd (9.6, 6.6) 17.8 t 15.9 t
2″ 1.62b (2H) 40.9 t 39.5 t 1″, 4″
3″ - 73.7 s 73.2 s 5″, 4″
Me-4″ 1.24 (3H) s 27.2 q 26.4 q
5″ 1.51 (2H) dd (11.4, 5.1) 42.4 t 41.6 t 6″, 4″
6″ 2.10 (2H) m 23.8 t 22.7 t
7″ 5.14 brt (6.3) 126.1 d 124.3 d 6″, 9″, 10″
8″ - 131.9 s 131.7 s 6″, 9″, 10″
Me-9″ 1.69 (3H) s 25.9 q 25.6 q 10″






Multiplicity has been determined by DEPT experiments and assignments have been made by HSQC.
d
CDCl3/MeOD 9:1.
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Table 3
Effects of 1–11 against tumor cell line replication
compound
GI50 (μM)
KB KB-VIN A549 DU145
1 NA 8.7 9.3 8.4
2 NA 15.8 14.6 18.3
3 16.3 10.8 NA 20.3
4 10.0 8.2 7.9 9.9
5 NA 18.2 NA NA
6 17.4 21.3 20.7 22.5
7 NA NA NA NA
8 14.1 8.7 11.0 12.6
9 21.2 13.8 NA NA
10 NA NA NA NA
11 13.3 9.0 9.5 8.1
Paclitaxel 5.9 nM >1000 nM 6.5 nM 3.3 nM
a
Cell line: KB = nasopharynx; KB-VIN = nasopharynx MDR, A549 = lung; DU145 = prostate.
NA = not active
Phytochemistry. Author manuscript; available in PMC 2012 October 01.
